CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Onyx Therapeutics, Inc. v. InnoPharma Inc.

1:16-cv-01036

Overview

Case Number 1:16-cv-01036
Filing Date 2016-11-08
Status Terminated
Termination Date 2019-05-08
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

InnoPharma Inc. Operating Company

Represented By

4 Attorneys Listed

Sam Kwon

Email: sam.kwon@kirkland.com

Jeanna Wacker

Email: jeanna.wacker@kirkland.com

David A. Bilson

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200
Fax: +1 (302) 655-4210

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Plaintiff

Onyx Therapeutics, Inc. Operating Company

Represented By

6 Attorneys Listed

Wendy A. Whiteford

Email: wendy@amgen.com

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Margaret A. O'Boyle

Email: moboyle@omm.com

Lisa Barons Pensabene

O'Melveny & Myers LLP

Tel: +1 (212) 326-2077
Fax: +1 (212) 326-2061

7 Times Square, Times Square Tower, New York, NY 10036

Brian Kao

UNDELIVERABLE 6/11/2020

UNDELIVERABLE 6/11/2020

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 1 proceeding
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (1 found):
U.S. Courts: 1
U.S. District Court 2016-10-26
1:16-cv-01000

Onyx Therapeutics, Inc. v. Sagent Pharmaceuticals, Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7417042
Compounds for enzyme inhibition
Filed: 2005-08-08
Issued: 2008-08-26
Active (0.8 yrs remaining) +765d PTA
Expires: 2027-09-12
US7737112
Composition for enzyme inhibition
Filed: 2005-12-07
Issued: 2010-06-15
Active (1.1 yrs remaining) +742d PTA
Expires: 2027-12-19
US8207297
Compounds for enzyme inhibition
Filed: 2011-12-22
Issued: 2012-06-26
Active (5.1 yrs remaining)
Expires: 2031-12-22

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+765 days) / Cellect Scrutiny β€” Over 765 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

7

Dispositive

0

Granted

0

Denied

0

Pending / Review

4

Motions by Category

Procedural / Extension Motion 6 Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. These actions are consolidated for purposes of discovery and all paper...
Entry #23 • 2017-04-18 Document →
Procedural / Extension Motion Pending
SO ORDERED, re (21 in 1:16-cv-01036-LPS, 17 in 1:16-cv-01000-LPS, 18 in 1:16-cv-01013-LPS, 18 in 1:16-cv-01001-LPS, 22 in 1:16-cv-01039-LPS, 25 in 1:16-cv-01012...
Entry #β€” • 2017-03-27
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to March 29, 2017 - filed by Onyx Therapeutics, Inc.. (Noreika, Maryellen) (Ent...
Entry #21 • 2017-03-22 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 16 STIPULATION TO EXTEND TIME for defendant to supplement or amend its counterclaims and the time for plaintiff to answer, move, or othewise resp...
Entry #β€” • 2017-01-19
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for defendant to supplement or amend its counterclaims and the time for plaintiff to answer, move, or othewise respond to the counter...
Entry #16 • 2017-01-17 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 7 STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to December 29, 2016 filed by InnoPharma Inc. Signed by Judge Leon...
Entry #β€” • 2016-11-30

Docket Entries

(58 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMNET filed against InnoPharma Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2026714.) - filed by Onyx Therapeutics, Inc.. (Attachments: # 1 Exhibit A - C, # 2 Civil Cover Sheet)(lmm) (Entered: 11/08/2016)

Entry #1 • 2016-11-07
1
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMNET filed against InnoPharma Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2026714.) - filed by Onyx Therapeutics, Inc.. (Attachments: # 1 Exhibit A - C, # 2 Civil Cover Sheet)(lmm) (Entered: 11/08/2016)

Entry #1 • 2016-11-07
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMNET filed against InnoPharma Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2026714.) - filed by Onyx Therapeutics, Inc.. (Attachments: # 1 Exhibit A - C, # 2 Civil Cover Sheet)(lmm) (Entered: 11/08/2016)

Entry #1 • 2016-11-07
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lmm) (Entered: 11/08/2016)

Entry #2 • 2016-11-07
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/26/2016. Date of Expiration of Patent: See attached.Thirty Month Stay Deadline: 1/20/2020. (lmm) (Entered: 11/08/2016)

Entry #3 • 2016-11-07
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc